CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to enhance radiotherapy outcomes by integrating novel biological concepts to personalize treatment for cancer patients. It focuses on understanding tumor responses and improving therapeutic strategies.
Radiotherapy alone or in multimodality approaches is applied in 45-60% of all cancer patients, but despite technical innovations approximately only 50% are cured.
Disease recurrence may be due to regrowth of the primary tumor or metastatic outgrowth.
Intrinsic and acquired resistance of the tumor and adverse reactions in the co-irradiated surrounding normal tissues dampen a successful therapy outcome.
Substantial improvements are now expected from biologically optimized, personalized radiotherap…
UNIVERSITAT ZURICH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Essen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Netherlands, Maastricht
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Dresden
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Belgium, Louvain La Neuve
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
